EUVIMEDEUVIMED entdecken
Open Access

Structural basis of herpesvirus helicase-primase inhibition by pritelivir and amenamevir

Andrey G Baranovskiy iD, Qixiang He iD, Yoshiaki Suwa iD, Lucia M Morstadt iD, Nigar D Babayeva iD, Ci Ji Lim iD, Tahir H Tahirov iD

Science Advances · 07.11.2025 · 11 (45)

DOI: 10.1126/sciadv.adz1989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 07.11.2025. Verfasst von Andrey G Baranovskiy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, U…. Hauptthemen laut MEDLINE: DNA Helicases, Viral Proteins, DNA Primase, Virus Replication. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Widespread herpesvirus infections are associated with various diseases. DNA replication of human herpes simplex virus type 1 (HSV-1) requires a helicase-primase (HP) complex of three core proteins: UL5, UL52, and UL8. This complex unwinds viral DNA and synthesizes primers for DNA replication, making it an attractive antiviral target. Although HP inhibitors pritelivir and amenamevir were identified through screening, their binding mechanisms remain unclear. Here, we report cryo–electron microscopy structures of HSV-1 HP bound to a forked DNA template alone and in complex with pritelivir or amenamevir. The structures reveal a bilobed architecture highlighting HP coordinated action at the replication fork and providing a structural basis for HP inhibition by illustrating precisely how pritelivir and amenamevir block helicase activity. Data lay a solid foundation for the development of improved antiviral therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA HelicasesViral ProteinsDNA PrimaseVirus ReplicationAntiviral AgentsDNA ReplicationHerpesvirus 1, HumanHerpes SimplexCryoelectron MicroscopyOxadiazolesSulfonamidesThiazolesProtein BindingDNA, ViralHumansSf9 CellsSpodopteraAnimalsMolecular Docking Simulation

Substanzen

helicase-primase, Human herpesvirus 1DNA HelicasesViral ProteinsDNA PrimasepritelivirASP2151OxadiazolesAntiviral AgentsSulfonamidesThiazoles

Autor:innen und Institutionen

  • Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.
  • Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA.

ORCID-Profile: Andrey G Baranovskiy, Qixiang He, Yoshiaki Suwa, Lucia M Morstadt, Nigar D Babayeva, Ci Ji Lim, Tahir H Tahirov

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Baranovskiy, A. G., He, Q., Suwa, Y., Morstadt, L. M., Babayeva, N. D., Lim, C. J., & Tahirov, T. H. (2025). Structural basis of herpesvirus helicase-primase inhibition by pritelivir and amenamevir. Science Advances, 11(45). https://doi.org/10.1126/sciadv.adz1989

Vancouver

Baranovskiy AG, He Q, Suwa Y, Morstadt LM, Babayeva ND, Lim CJ, et al. Structural basis of herpesvirus helicase-primase inhibition by pritelivir and amenamevir. Science Advances. 2025;11(45). doi:10.1126/sciadv.adz1989

BibTeX
@article{Baranovskiy2025,
  author = {Baranovskiy, Andrey G and He, Qixiang and Suwa, Yoshiaki and Morstadt, Lucia M and Babayeva, Nigar D and Lim, Ci Ji and Tahirov, Tahir H},
  title = {Structural basis of herpesvirus helicase-primase inhibition by pritelivir and amenamevir},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {45},
  doi = {10.1126/sciadv.adz1989}
}
Kostenlos starten →